Latest Advances in Lung Cancer Research

FDA approves new liquid biopsy tests using NGS to detect tumor DNA, aiding targeted cancer therapy selection.

Lung cancer screenings down due to COVID. Drop in lung cancer screenings due to canceled or postponed services has led to worse patient outcomes.

Tagrisso as adjuvant therapy for non-small cell lung cancer approved by the FDA for patients who have had tumor resection.

Amgen has filed its trailblazer KRAS inhibiting drug treatment with the FDA for a group of lung cancer patients with an aggressive form of the disease.